At Nielsen
Janssen-Cilag
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by At Nielsen.
Value in Health | 2015
D Belhadi; V Taieb; At Nielsen; M. Hemels; J Van Laer
Objective • Asthma is a respiratory disease characterised by episodes of obstruction of the airways which are reversible by medication. • Severe asthma is the most difficult-to-treat type as it is usually refractory to most treatments and requires combinations of high doses of ICS/LABA and additional oral medication to control symptoms. [1,2,3] • Studies have shown that the large majority of severe asthmatic patients have high numbers of eosinophils present in their airway tissue which is believed to be important in the pathology of the disease [4,5]. As a result, biological therapies such as omalizumab which target immunoglobulins E (IgE) have been used in the recent years to treat severe asthma patients.
Value in Health | 2013
M Pacou; V Taieb; K.R. Abrams; Joris Diels; S. van Sanden; M. Garg; M. Schroeder; V. Kaur; At Nielsen; S. Nuhoho; C. Neslusan; M. Hemels
Value in Health | 2015
V Taieb; M Pacou; M. Schroeder; At Nielsen; A Schubert; C. Neslusan
Value in Health | 2015
Vanessa Taieb; M Pacou; M. Schroeder; A Schubert; At Nielsen
Value in Health | 2015
S. Van Sanden; Joris Diels; P. Guillon; At Nielsen
Value in Health | 2015
At Nielsen; A. Pitcher; E. Lovato; A Schubert; M. Hemels; C. Neslusan; B. González
Value in Health | 2015
V Taieb; M Pacou; M. Schroeder; At Nielsen; C. Neslusan; A Schubert
Value in Health | 2015
M. Schroeder; V Taieb; D Belhadi; C. Seyla-Hammer; M. Hemels; At Nielsen
Value in Health | 2015
A Schubert; At Nielsen; A El Khoury; A Kamal; Vanessa Taieb
Value in Health | 2015
At Nielsen; A. Pitcher; E. Lovato; A. Schubert; M. Hemels; C. Neslusan; B. González
